Germany In The News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Germany In The News.

Press releases published on October 1, 2026

Oct. 1, 2026

Review Finds Four EU Accessibility Act Fines in 15 Months, All in Czechia

Indeterminate EIN Presswire

Oct. 1, 2026

Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain

Indeterminate EIN Presswire

Oct. 1, 2026

Tenorshare 4uKey for Android unterstützt Android 17 bei Sperren und FRP

Indeterminate EIN Presswire

Oct. 1, 2026

CANOPY BRANDS ACQUIRES FRANCE-BASED FIXATOR, EXPANDING WORKING-AT-HEIGHT CAPABILITIES

Indeterminate EIN Presswire

Oct. 1, 2026

Tomorrow.io selects SIL’s Payload PDU technology for the precipitation radar aboard its DeepSky satellite constellation

Indeterminate EIN Presswire

Oct. 1, 2026

TRANSFORMING.LEGAL to Lead DACH Legal AI and Legal Operations Study with CLOC

Indeterminate EIN Presswire

Oct. 1, 2026

AIOMEGA Announces National Breathe Academy to Train Clinicians in FDA Cleared Adult and Pediatric OSA Treatment Pathways

Indeterminate EIN Presswire

Oct. 1, 2026

PubHive Named Best Life Sciences Workflow SaaS Platform 2026

Indeterminate EIN Presswire

Oct. 1, 2026

Das Rennen um SASE-Features ist entschieden. Jetzt beginnt das Rennen um AI Operations

Indeterminate EIN Presswire

Oct. 1, 2026

Heimdal partners with Elovade to bring unified cybersecurity platform to the DACH region

Indeterminate EIN Presswire

Oct. 1, 2026

EPC to Showcase Next-Generation GaN Solutions for AI, Robotics, Space and Autonomous Machines at Electronica 2026

Indeterminate EIN Presswire

Oct. 1, 2026

HERO CNC setzt neue Maßstäbe in der Präzisionszerspanung und Baugruppenmontage

Indeterminate EIN Presswire

Oct. 1, 2026

JEDMED Announces Acquisition of Oak Tree Group LLC

Indeterminate EIN Presswire

Oct. 1, 2026

InflaRx Appoints Gabriela Alperovich, MD, PhD, as Senior Vice President & Global Head of Clinical Development

Indeterminate GlobeNewswire

Oct. 1, 2026

Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board

Indeterminate GlobeNewswire

Oct. 1, 2026

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Indeterminate GlobeNewswire